APOLIPOPROTEIN A-I GENE POLYMORPHISM AND ATHEROSCLEROSIS
APOLIPOPROTEIN A-I GENE POLYMORPHISM AND ATHEROSCLEROSIS
批准号:
3348940
负责人:
ERNST JOHN SCHAEFER
金额:
$11.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-12-01 至 1988-11-30
关键词:
angiocardiography apolipoproteins atherosclerosis biological polymorphism cardiovascular disorder diagnosis cardiovascular disorder epidemiology cholesterol clinical chemistry coronary disorder disease /disorder proneness /risk familial hyperlipoproteinemia gel electrophoresis gene expression high density lipoproteins human subject linkage mapping molecular pathology population genetics radioassay
中文摘要
载脂蛋白(apo) A-I是血浆高的主要蛋白质成分
英文摘要
Apolipoprotein (apo) A-I is the major protein constituent of plasma high
density lipoproteins (HDL). HDL has been shown to promote cholesterol
efflux from cells in vitro. Decreased plasma concentrations of HDL
cholesterol and apoA-I have been associated with premature coronary artery
disease (CAD) due to atherosclerosis in our society. Genetic HDL
deficiency (familial hypoalphalipoproteinemia) appears to be fairly common
in patients with premature CAD. The gene for apoA-I has been isolated and
characterized. Our preliminary studies indicate that a specific apoA-I
gene polymorphism, detected following Pst I restriction enzyme digestion
utilizing a specific probe, is significantly more common in subjects with
premature CAD (32.8%) than in normal control subjects (3.9%), and in some
kindreds is associated with genetic HDL deficiency. This apoA-I gene
polymorphism is due to an alteration in the apoA-I, apoC-III intergenic
region, near the 3' end of the coding region for ApoA-I.
Our specific aims are: 1) to determine the prevalence of genetic HDL
cholesterol and apoA-I deficiency and the Pst I apoA-I gene polymorphism in
patients with premature CAD and their first degree relatives utilizing
standard lipid analysis, immunoassay and Southern blotting; 2) to assess
whether the risk of developing premature CAD is associated with the gene
polymorphism; 3) to ascertain the relationship between HDL deficiency, the
Pst I gene polymorphism, and premature CAD by linkage analysis; 4) to
isolate and characterize the abnormal apoA-I, apoC-III gene complex by gene
mapping studies with multiple restriction enzymes, and by cloning and
sequencing methods. These studies will allow us to test the following
hypotheses:
1. The Pst I apoA-I gene polymorphism is associated with genetic HDL
deficiency and premature CAD;
2. Genetic HDL deficiency associated with the Pst I apoA-I gene
polymorphism is a common familial lipoprotein disorder in patients with
premature CAD;
3. The Pst I apoA-I gene polymorphism is due to a specific mutation in the
apoA-I, apoC-III intergenic region, which directly or indirectly (via a
linked polymorphism) affects apoA-I synthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core--Laboratory and Data Management
-
批准号:7140959
-
项目类别:
-
资助金额:$21.03万
-
财政年份:2006
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
EFFECTS OF EXTENDED-RELEASE NIACIN ON A COMBINATION OF LOVASTATIN
-
批准号:7200872
-
项目类别:
-
资助金额:$0.77万
-
财政年份:2005
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
Effects of Extended-Release Niacin on a Combination
-
批准号:7040665
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2004
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
Effects of Atorvastatin on the Kinetics of APO B-100
-
批准号:7040659
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2004
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
Pharmacogenetics of the Statin Response
-
批准号:7119521
-
项目类别:
-
资助金额:$81.7万
-
财政年份:2003
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
Pharmacogenetics of the Statin Response
-
批准号:6805273
-
项目类别:
-
资助金额:$79.13万
-
财政年份:2003
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
Pharmacogenetics of the Statin Response
-
批准号:6698877
-
项目类别:
-
资助金额:$70.3万
-
财政年份:2003
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
Pharmacogenetics of the Statin Response
-
批准号:6933896
-
项目类别:
-
资助金额:$83.68万
-
财政年份:2003
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
MOLECULAR BASIS OF HIGH DENSITY LIPOPROTEIN DEFICIENCY
-
批准号:2854266
-
项目类别:
-
资助金额:$30.04万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
Molecular Basis of High Density Lipoprotein Deficiency
-
批准号:7054062
-
项目类别:
-
资助金额:$31.46万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
Molecular Basis of High Density Lipoprotein Deficiency
-
批准号:6926809
-
项目类别:
-
资助金额:$31.7万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
Molecular Basis of High Density Lipoprotein Deficiency
-
批准号:7416663
-
项目类别:
-
资助金额:$33.82万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
DIETARY COMPOSITION, OBESITY, AND CARDIOVASCULAR RISK
-
批准号:6537285
-
项目类别:
-
资助金额:$41.89万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
DIETARY COMPOSITION, OBESITY, AND CARDIOVASCULAR RISK
-
批准号:2909036
-
项目类别:
-
资助金额:$39.12万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
MOLECULAR BASIS OF HIGH DENSITY LIPOPROTEIN DEFICIENCY
-
批准号:6165080
-
项目类别:
-
资助金额:$27.92万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
Molecular Basis of High Density Lipoprotein Deficiency
-
批准号:7623881
-
项目类别:
-
资助金额:$33.36万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
DIETARY COMPOSITION, OBESITY, AND CARDIOVASCULAR RISK
-
批准号:6638463
-
项目类别:
-
资助金额:$17.63万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
MOLECULAR BASIS OF HIGH DENSITY LIPOPROTEIN DEFICIENCY
-
批准号:6363558
-
项目类别:
-
资助金额:$28.53万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
DIETARY COMPOSITION, OBESITY, AND CARDIOVASCULAR RISK
-
批准号:6389608
-
项目类别:
-
资助金额:$40.67万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
DIETARY COMPOSITION, OBESITY, AND CARDIOVASCULAR RISK
-
批准号:6183821
-
项目类别:
-
资助金额:$39.48万
-
财政年份:1999
-
负责人:ERNST JOHN SCHAEFER
-
依托单位:
海外基金